SE381047B - Forfarande for framstellning av 3-substituerade 1,2-bensisoxazolderivat - Google Patents

Forfarande for framstellning av 3-substituerade 1,2-bensisoxazolderivat

Info

Publication number
SE381047B
SE381047B SE7303717A SE7303717A SE381047B SE 381047 B SE381047 B SE 381047B SE 7303717 A SE7303717 A SE 7303717A SE 7303717 A SE7303717 A SE 7303717A SE 381047 B SE381047 B SE 381047B
Authority
SE
Sweden
Prior art keywords
bensisoxazole
derivatives
substituted
procedure
preparation
Prior art date
Application number
SE7303717A
Other languages
English (en)
Swedish (sv)
Inventor
H Nishimura
M Shimizu
H Uno
T Hirooka
Y Masuda
M Kurokawa
Original Assignee
Dainippon Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2786572A external-priority patent/JPS5545545B2/ja
Priority claimed from JP2786672A external-priority patent/JPS5616154B2/ja
Application filed by Dainippon Pharmaceutical Co filed Critical Dainippon Pharmaceutical Co
Publication of SE381047B publication Critical patent/SE381047B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7303717A 1972-03-17 1973-03-16 Forfarande for framstellning av 3-substituerade 1,2-bensisoxazolderivat SE381047B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2786572A JPS5545545B2 (nl) 1972-03-17 1972-03-17
JP2786672A JPS5616154B2 (nl) 1972-03-17 1972-03-17

Publications (1)

Publication Number Publication Date
SE381047B true SE381047B (sv) 1975-11-24

Family

ID=26365855

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7303717A SE381047B (sv) 1972-03-17 1973-03-16 Forfarande for framstellning av 3-substituerade 1,2-bensisoxazolderivat

Country Status (10)

Country Link
US (1) US3948928A (nl)
AU (1) AU466970B2 (nl)
CA (1) CA1025857A (nl)
CH (1) CH577984A5 (nl)
DK (1) DK140498B (nl)
ES (1) ES412813A1 (nl)
FR (1) FR2181831B1 (nl)
GB (1) GB1416071A (nl)
NL (1) NL168833C (nl)
SE (1) SE381047B (nl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4728662A (en) * 1977-11-21 1988-03-01 Hoechst-Roussel Pharmaceuticals Inc. 1,2-benzisoxazoloxyacetic acids and related compounds
US4673746A (en) * 1978-10-06 1987-06-16 Hoechst-Roussel Pharmaceuticals, Inc. 1,2-benzisoxazoloxyacetic acids and related compounds
US4536578A (en) * 1982-04-09 1985-08-20 Hoechst-Roussel Pharmaceuticals Inc. 1-[3-(6-Fluoro-1,2-benzisoxazol-3-yl)propyl]-4-(substituted)piperazines
US4610988A (en) * 1982-04-09 1986-09-09 Hoechst-Roussel Pharmaceuticals Inc. 1-[3-(6-fluoro-1,2-benzisoxazol-3-yl)propyl]-4-(substituted)piperazines useful for alleviating pain
US4609658A (en) * 1982-04-09 1986-09-02 Hoechst-Roussel Pharmaceuticals Inc. 1-[3-(6-fluoro-1,2-benzisoxazol-3-yl)propyl]-4-(substituted) piperazines useful for reducing blood pressure
JPS58201770A (ja) * 1982-05-18 1983-11-24 Dainippon Pharmaceut Co Ltd α−置換−１，２−ベンズイソキサゾ−ル−３−酢酸エステル類並びにその酸付加塩類及び第４級アンモニウム塩類
DE602006001511D1 (de) * 2005-02-04 2008-07-31 Ctg Pharma S R L Neue 4-aminochinolinderivate als antimalariamittel
ME02461B (me) 2005-05-10 2017-02-20 Incyte Holdings Corp Modulatori indoleamina 2,3-dioksigenaze i metode za upotrebu istih
ES2540561T3 (es) 2005-12-20 2015-07-10 Incyte Corporation N-hidroxiamidinoheterociclos como moduladores de indolamina 2,3-dioxigenasa
WO2007081335A1 (en) * 2006-01-12 2007-07-19 Merck & Co., Inc. Therapeutic compounds for treating dyslipidemic conditions
CL2007002650A1 (es) 2006-09-19 2008-02-08 Incyte Corp Compuestos derivados de heterociclo n-hidroxiamino; composicion farmaceutica, util para tratar cancer, infecciones virales y desordenes neurodegenerativos entre otras.
US20080146624A1 (en) * 2006-09-19 2008-06-19 Incyte Corporation Amidines as modulators of indoleamine 2,3-dioxygenase
CA2663057C (en) * 2006-09-19 2015-12-08 Incyte Corporation N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
US20080182882A1 (en) * 2006-11-08 2008-07-31 Incyte Corporation N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
US20100168192A1 (en) * 2007-05-24 2010-07-01 Neurosearch A/S Benzisoxazole derivatives as potassium channel modulators for the treatment of e.g. respiratory diseases, epilepsy and convulsions
MY171866A (en) 2008-07-08 2019-11-05 Incyte Holdings Corp 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
PL3066085T3 (pl) 2013-11-08 2020-11-02 Incyte Holdings Corporation Sposób syntezy inhibitora 2,3-dioksygenazy indoloaminowej

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670497C3 (de) * 1967-06-06 1973-12-20 Chinoin Gyogyszer- Es Vegyeszeti Termekek Gyara Rt, Budapest Isochinohnderivate und Verfahren zu deren Herstellung

Also Published As

Publication number Publication date
DK140498C (nl) 1980-03-17
DK140498B (da) 1979-09-17
US3948928A (en) 1976-04-06
FR2181831A1 (nl) 1973-12-07
CA1025857A (en) 1978-02-07
AU5347973A (en) 1974-09-19
FR2181831B1 (nl) 1975-10-10
AU466970B2 (en) 1975-11-13
ES412813A1 (es) 1976-07-01
NL168833C (nl) 1982-05-17
GB1416071A (en) 1975-12-03
NL168833B (nl) 1981-12-16
CH577984A5 (nl) 1976-07-30
NL7303682A (nl) 1973-09-19

Similar Documents

Publication Publication Date Title
SE402592B (sv) Forfarande for framstellning av 2-alkyl-3-acyl-pyrazolo(1,5-a)pyridiner
SE390819B (sv) Analogiforfarande for framstellning av piperazinyl-propyl-1,2,4-triazolinderivat
SE381047B (sv) Forfarande for framstellning av 3-substituerade 1,2-bensisoxazolderivat
SE395149B (sv) Forfarande for framstellning av dibenso-tiepinylpiperazinderivat
SE417968B (sv) Forfarande for framstellning av penamderivat
SE401676B (sv) Forfarande for framstellning av dibensofuranderivat
SE397530B (sv) Forfarande for framstellning av 1-pyrazolylalkyl-4-arylpiperazinderivat
SE385698B (sv) Forfarande for framstellning av kinolinettiksyraderivat
SE420604B (sv) Forfarande for framstellning av oxazolderivat
SE399425B (sv) Forfarande for framstellning av 1-fenoxi-3-aminopropan-2-ol-derivat
SE399708B (sv) Forfarande for framstellning av tioxanton-2-karboxylsyraderivat
SE402009B (sv) Forfarande for framstellning av 9-desoxi-prosta-5,9,(10),13-triensyraderivat
SE400768B (sv) Forfarande for framstellning av 2-fenyl-6-sulfamoyl-7-klor-1,2,3,4-tetrahydro-4-kinazolinon
SE387344B (sv) Forfarande for framstellning av pyrazin-4-oxidderivat
SE399557B (sv) Forfarande for framstellning av tiantren-, tioxanten- och fenoxatiinderivat
SE416470B (sv) Analogiforfarande for framstellning av 3-substituerade as-triazino-(5,6-c)kinolinderivat
SE400278B (sv) Forfarande for framstellning av fenylketonderivat
FI52735C (fi) Menetelmä uusien pregnadieeni-21-happojohdannaisten valmistamiseksi.
SE7613500L (sv) Forfarande for framstellning av cefemderivat
SE400086B (sv) Forfarande for framstellning av acylerade n(6)- aralkyl-adenosin-derivat
SE398351B (sv) Forfarande for framstellning av ditino-(1,4)-(2,3-c)pyrrol-piperazinderivat
SE403112B (sv) Analogiforfarande for framstellning av skopolaminderivat
SE419441B (sv) Forfarande for framstellning av butyrofenonderivat
SE409325B (sv) Forfarande for framstellning av kinazolinonderivat
SE399254B (sv) Forfarande for framstellning av kinazolinonderivat